NEOS Investment Management LLC Buys 1,241 Shares of Humana Inc. (NYSE:HUM)

NEOS Investment Management LLC boosted its stake in Humana Inc. (NYSE:HUM) by 27.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,697 shares of the insurance provider’s stock after purchasing an additional 1,241 shares during the quarter. NEOS Investment Management LLC’s holdings in Humana were worth $1,445,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in HUM. Dynamic Technology Lab Private Ltd bought a new stake in Humana during the 3rd quarter worth approximately $404,000. Glenmede Trust Co. NA increased its holdings in shares of Humana by 7.6% in the third quarter. Glenmede Trust Co. NA now owns 25,718 shares of the insurance provider’s stock worth $8,146,000 after purchasing an additional 1,813 shares during the period. CreativeOne Wealth LLC purchased a new stake in shares of Humana in the third quarter worth $208,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Humana by 1.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 856,954 shares of the insurance provider’s stock valued at $271,432,000 after buying an additional 9,100 shares during the period. Finally, Public Sector Pension Investment Board grew its position in Humana by 13.0% during the third quarter. Public Sector Pension Investment Board now owns 5,222 shares of the insurance provider’s stock worth $1,654,000 after buying an additional 600 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.37% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HUM. Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. StockNews.com lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. JPMorgan Chase & Co. decreased their price target on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Finally, Truist Financial increased their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Eighteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $285.68.

Humana Price Performance

HUM opened at $263.95 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $31.86 billion, a PE ratio of 26.53, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The stock’s 50 day moving average price is $270.14 and its 200-day moving average price is $273.87. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana’s payout ratio is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.